Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin–binding phosphoprotein 50 in cholangiocarcinoma

Sripa, 2003, Opisthorchis viverrini and opisthorchiasis: the 21st century review, Acta Trop, 88, 169, 10.1016/j.actatropica.2003.08.001 Sripa, 2007, Liver fluke induces cholangiocarcinoma, PLoS Med, 4, e201, 10.1371/journal.pmed.0040201 Bouvard, 2009, A review of human carcinogens B: biological agents, Lancet Oncol, 10, 321, 10.1016/S1470-2045(09)70096-8 Yonglitthipagon, 2010, Up-regulation of annexin A2 in cholangiocarcinoma caused by Opisthorchis viverrini and its implication as a prognostic marker, Int J Parasitol, 40, 1203, 10.1016/j.ijpara.2010.05.002 Sripa, 2005, Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100), World J Gastroenterol, 11, 3392, 10.3748/wjg.v11.i22.3392 Fedor, 2005, Practical methods for tissue microarray construction, Methods Mol Med, 103, 89 van Diest, 1997, A scoring system for immunohistochemical staining: consensus report of the Task Force for Basic Research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer–Gynaecological Cancer Cooperative Group, J Clin Pathol, 50, 801, 10.1136/jcp.50.10.801 Zhuang, 2008, Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor, Cancer, 112, 2740, 10.1002/cncr.23488 Zhong, 2003, Antibodies to HSP70 and HSP90 in serum in non–small cell lung cancer patients, Cancer Detect Prev, 27, 285, 10.1016/S0361-090X(03)00097-7 Desmetz, 2008, Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ, J Proteome Res, 7, 3830, 10.1021/pr800130d Chang, 2003, Enolase-alpha is frequently down-regulated in non–small cell lung cancer and predicts aggressive biological behavior, Clin Cancer Res, 9, 3641 David CJ, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463:364-8. Kim, 2007, Elevated peroxiredoxin 1, but not NF-E2–related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non–small cell lung cancer, Clin Cancer Res, 13, 3875, 10.1158/1078-0432.CCR-06-2893 Song, 2007, Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin–binding phosphoprotein 50 in breast cancer, Histopathology, 51, 40, 10.1111/j.1365-2559.2007.02730.x Hay, 1988 Rhee, 2001, Peroxiredoxin, a novel family of peroxidases, IUBMB Life, 52, 35, 10.1080/15216540252774748 Kim, 2006, Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex, Cancer Res, 66, 7136, 10.1158/0008-5472.CAN-05-4446 Cha, 2009, Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma, J Exp Clin Cancer Res, 28, 93, 10.1186/1756-9966-28-93 Yanagawa, 2000, Peroxiredoxin I expression in oral cancer: a potential new tumor marker, Cancer Lett, 156, 27, 10.1016/S0304-3835(00)00434-1 Chang, 2001, Augmented expression of peroxiredoxin I in lung cancer, Biochem Biophys Res Commun, 289, 507, 10.1006/bbrc.2001.5989 Pinlaor, 2004, Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis, Nitric Oxide, 11, 175, 10.1016/j.niox.2004.08.004 Wu, 2010, Peroxiredoxins in colorectal neoplasms, Histol Histopathol, 25, 1297 Berggren, 2001, Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin, Arch Biochem Biophys, 392, 103, 10.1006/abbi.2001.2435 Kim, 2008, A novel function of peroxiredoxin 1 (Prx-1) in apoptosis signal-regulating kinase 1 (ASK1)–mediated signaling pathway, FEBS Lett, 582, 1913, 10.1016/j.febslet.2008.05.015 Reczek, 1997, Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family, J Cell Biol, 139, 169, 10.1083/jcb.139.1.169 Maudsley, 2000, Platelet-derived growth factor receptor association with Na+/H+ exchanger regulatory factor potentiates receptor activity, Mol Cell Biol, 20, 8352, 10.1128/MCB.20.22.8352-8363.2000 Cardone, 2007, The NHERF1 PDZ2 domain regulates PKA-RhoA-p38–mediated NHE1 activation and invasion in breast tumor cells, Mol Biol Cell, 18, 1768, 10.1091/mbc.E06-07-0617 Shibata, 2003, EBP50, a beta-catenin–associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma, Hepatology, 38, 178, 10.1053/jhep.2003.50270 Lazar, 2004, The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface, Mol Biol Cell, 15, 5470, 10.1091/mbc.E04-03-0239 Kreimann, 2007, Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function, Oncogene, 26, 5290, 10.1038/sj.onc.1210336 Pan, 2008, Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells, Breast Cancer Res, 10, R5, 10.1186/bcr1846 Georgescu, 2008, NHERF1: molecular brake on the PI3K pathway in breast cancer, Breast Cancer Res, 10, 106, 10.1186/bcr1992 Stemmer-Rachamimov, 2001, NHE-RF, a Merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas, Am J Pathol, 158, 57, 10.1016/S0002-9440(10)63944-2 Uttaravichien, 1999, Intrahepatic cholangiocarcinoma in Thailand, J Hepato-Biliary-Pancreatic Surg, 6, 128, 10.1007/s005340050095 Nathan, 2007, Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis, J Gastrointest Surg, 11, 1488, 10.1007/s11605-007-0282-0